Researchers at the Indiana University School of Medicine have identified a promising new target for treating Alzheimer’s ...

"We're going to see more drugs and better drugs soon, and I think that's very exciting. But we can't just focus on the drugs, we need to rethink our system of care," said coauthor Katherine L. Possin, ...

Collaborative Alzheimer’s care improved quality of life and saved billions when scaled nationwide, outperforming the antiamyloid drug lecanemab, results of a new cost analysis suggest.

Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team ...

Is the IDOL enzyme the key to stopping Alzheimer's? New research shows that blocking this single target can dissolve brain plaques and boost cognitive resilience.

We are truly in a new era. We have opened the door to understanding and manipulating the biology of Alzheimer's disease for the benefit of our patients," NEWARK, DE / ACCESS Newswire / February 12, ...

The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

While physicians and scientists have long known Alzheimer's disease involves the buildup of toxic protein fragments in the ...

Scientists at Northwestern University say a common anti-seizure medication may be able to prevent the earliest steps of Alzheimer’s disease—long before memory loss begins. In a study published in ...

Studies reveal the therapeutic mechanism of action for levetiracetam to prevent the production of Aβ and, consequently, downstream irreversible damage.

Researchers engineered CD4+ chimeric antigen receptor T cells targeting fibrillar amyloid beta and tested them in a mouse ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...